HomeESLA • NASDAQ
add
Estrella Immunopharma Inc
Previous close
$0.96
Day range
$0.95 - $1.00
Year range
$0.63 - $3.23
Market cap
34.69M USD
Avg Volume
70.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.10M | 348.17% |
Net income | -2.10M | -348.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 421.47K | -98.10% |
Total assets | 3.74M | -86.34% |
Total liabilities | 2.99M | -82.70% |
Total equity | -1.83M | — |
Shares outstanding | 36.17M | — |
Price to book | -19.22 | — |
Return on assets | -206.17% | — |
Return on capital | -335.81% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.10M | -348.17% |
Cash from operations | -465.98K | -69.33% |
Cash from investing | — | — |
Cash from financing | -29.46K | -100.15% |
Net change in cash | -495.44K | 88.53% |
Free cash flow | 548.82K | -76.21% |
About
Founded
2006
Headquarters
Website
